NCT06220591

Comparing Local Anesthetic Techniques for Clavicular Surgeries

Name: Clinical Trial NCT06220591
Creator: Zagazig University
Keywords: Anesthesia, Local, Superior trunk block, procedure, clinical trial, Egypt

Ultrasound-guided Selective Supraclavicular Nerve Block With Either Superior Trunk or Clavipectoral Fascial Plane Block for Clavicular Surgery

Zagazig University·ClinicalTrials.gov·procedureRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Anesthesia, Local
Drug/Device/Intervention: Superior trunk block
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Zagazig University
Location: Zagazig, Egypt

Timeline & enrollment

Phase: N/A
Start date: Dec 20, 2023
End date: Aug 01, 2024
Enrollment: 54 participants

Primary outcome

Time of the first rescue analgesic request by the patient postoperative.

Summary

Surgical fixation for acute clavicular fractures is increasingly preferred among orthopedic surgeons to improve healing and decrease the risk of malunion. Regional anesthesia for clavicular fractures allows rapid recovery, prolonged postoperative analgesia, and less opioid consumption, and so decreases the hospital stay. There is no consensus regarding the best regional anesthetic technique for surgical fixation for acute clavicular fractures. Selective supraclavicular nerve block combined with either superior trunk or clavipectoral fascial plane block is a promising regional anesthetic technique for midshaft clavicular surgeries.

ICD-10 classifications

Local anaestheticsAnaesthetic, unspecifiedOther and unspecified general anaestheticsPoisoning: Local anaestheticsParenteral anaesthetics

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06220591
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06220591 through Pure Global AI's free database. This phase not specified trial is sponsored by Zagazig University and is currently Recruiting. The study focuses on Anesthesia, Local. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.